Sanofi (SNYNF) Current Leases (2019 - 2025)
Sanofi (SNYNF) posted Current Leases of $316.6 million for Q4 2025, up 11.0% sequentially from $285.3 million in Q2 2025, and up 13.52% YoY from $278.9 million in Q4 2024.
Sanofi (SNYNF) Current Leases (2019 - 2025) Analysis & Trends
Sanofi (SNYNF) has 7 years of Current Leases data on file, last reported at $316.6 million in Q4 2025.
- Quarterly Current Leases rose 13.52% year-over-year to $316.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $316.6 million (up 13.52% YoY) and the FY2025 annual result came in at $316.6 million, up 13.52% from the prior year.
- Current Leases rose to $316.6 million in Q4 2025 per SNYNF's latest filing, from $285.3 million in the prior quarter.
- The five-year high for Current Leases was $316.6 million in Q4 2025, with the low at $246.5 million in Q2 2022.
- Average Current Leases over 5 years is $288.7 million, with a median of $290.6 million recorded in 2023.
- Year-over-year, Current Leases fell 17.13% in 2022 and gained 13.52% in 2025.
- Sanofi's Current Leases stood at $307.7 million in 2021, then fell by 8.16% to $282.6 million in 2022, then increased by 4.7% to $295.9 million in 2023, then dropped by 5.74% to $278.9 million in 2024, then rose by 13.52% to $316.6 million in 2025.
- Business Quant data shows SNYNF's Current Leases at $316.6 million in Q4 2025, $285.3 million in Q2 2025, and $278.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 271.00 Mn |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 316.62 Mn |
| Jun 30, 2025 | 285.25 Mn |
| Dec 31, 2024 | 278.90 Mn |
| Jun 30, 2024 | 300.45 Mn |
| Dec 31, 2023 | 295.88 Mn |
| Jun 30, 2023 | 275.50 Mn |
| Dec 31, 2022 | 282.61 Mn |
| Jun 30, 2022 | 246.49 Mn |
| Dec 31, 2021 | 307.73 Mn |
| Jun 30, 2021 | 297.46 Mn |
| Dec 31, 2020 | 276.61 Mn |
| Jun 30, 2020 | 273.16 Mn |
| Dec 31, 2019 | 2.44 Mn |
| Jun 30, 2019 | 269.67 Mn |